These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
989 related items for PubMed ID: 16302195
1. p53 apoptotic response to DNA damage dependent on bcl2 but not bax in head and neck squamous cell carcinoma lines. Crowe DL, Sinha UK. Head Neck; 2006 Jan; 28(1):15-23. PubMed ID: 16302195 [Abstract] [Full Text] [Related]
2. Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis. Andrews GA, Xi S, Pomerantz RG, Lin CJ, Gooding WE, Wentzel AL, Wu L, Sidransky D, Grandis JR. Head Neck; 2004 Oct; 26(10):870-7. PubMed ID: 15390206 [Abstract] [Full Text] [Related]
4. Bcl-2/Bax protein ratio predicts 5-fluorouracil sensitivity independently of p53 status. Mirjolet JF, Barberi-Heyob M, Didelot C, Peyrat JP, Abecassis J, Millon R, Merlin JL. Br J Cancer; 2000 Nov; 83(10):1380-6. PubMed ID: 11044365 [Abstract] [Full Text] [Related]
5. p53 mutations and p53, Waf-1, Bax and Bcl-2 expression in field cancerization of the head and neck. Lavieille JP, Gazzeri S, Riva C, Reyt E, Brambilla C, Brambilla E. Anticancer Res; 1998 Nov; 18(6B):4741-9. PubMed ID: 9891551 [Abstract] [Full Text] [Related]
6. Dissociation between cell cycle arrest and apoptosis can occur in Li-Fraumeni cells heterozygous for p53 gene mutations. Delia D, Goi K, Mizutani S, Yamada T, Aiello A, Fontanella E, Lamorte G, Iwata S, Ishioka C, Krajewski S, Reed JC, Pierotti MA. Oncogene; 1997 May 08; 14(18):2137-47. PubMed ID: 9174049 [Abstract] [Full Text] [Related]
7. Expression of apoptosis-related genes in human head and neck squamous cell carcinomas undergoing p53-mediated programmed cell death. Frederick MJ, Holton PR, Hudson M, Wang M, Clayman GL. Clin Cancer Res; 1999 Feb 08; 5(2):361-9. PubMed ID: 10037186 [Abstract] [Full Text] [Related]
8. A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function. Kokontis JM, Wagner AJ, O'Leary M, Liao S, Hay N. Oncogene; 2001 Feb 08; 20(6):659-68. PubMed ID: 11313999 [Abstract] [Full Text] [Related]
9. Effects of p53 or p27 overexpression on cyclooxygenase-2 gene expression in head and neck squamous cell carcinoma cell lines. Lee DW, Park SW, Park SY, Heo DS, Kim KH, Sung MW. Head Neck; 2004 Aug 08; 26(8):706-15. PubMed ID: 15287038 [Abstract] [Full Text] [Related]
10. Role of p53 in G2/M cell cycle arrest and apoptosis in response to gamma-irradiation in ovarian carcinoma cell lines. Concin N, Stimpfl M, Zeillinger C, Wolff U, Hefler L, Sedlak J, Leodolter S, Zeillinger R. Int J Oncol; 2003 Jan 08; 22(1):51-7. PubMed ID: 12469184 [Abstract] [Full Text] [Related]
11. The bcl-2 gene status of human head and neck cancer cell lines. Salo A, Servomaa K, Kiuru A, Pulkkinen J, Grénman R, Pekkola-Heino K, Rytömaa T. Acta Otolaryngol Suppl; 1997 Jan 08; 529():233-6. PubMed ID: 9288319 [Abstract] [Full Text] [Related]
12. Induction of BCL2 family member MCL1 as an early response to DNA damage. Zhan Q, Bieszczad CK, Bae I, Fornace AJ, Craig RW. Oncogene; 1997 Mar 06; 14(9):1031-9. PubMed ID: 9070651 [Abstract] [Full Text] [Related]
13. Oncogenic mutation of the p53 gene derived from head and neck cancer prevents cells from undergoing apoptosis after DNA damage. Kawamata H, Omotehara F, Nakashiro K, Uchida D, Shinagawa Y, Tachibana M, Imai Y, Fujimori T. Int J Oncol; 2007 May 06; 30(5):1089-97. PubMed ID: 17390010 [Abstract] [Full Text] [Related]
14. Regulators of proliferation and apoptosis in carcinoma of the larynx. Whisler LC, Wood NB, Caldarelli DD, Hutchinson JC, Panje WR, Friedman M, Preisler HD, Leurgans S, Nowak J, Coon JS. Laryngoscope; 1998 May 06; 108(5):630-8. PubMed ID: 9591537 [Abstract] [Full Text] [Related]
15. Apoptosis induction mediated by wild-type p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck. Liu TJ, el-Naggar AK, McDonnell TJ, Steck KD, Wang M, Taylor DL, Clayman GL. Cancer Res; 1995 Jul 15; 55(14):3117-22. PubMed ID: 7606733 [Abstract] [Full Text] [Related]
16. Protein levels of p21, p27, cyclin E and Bax predict sensitivity to cisplatin and paclitaxel in head and neck squamous cell carcinomas. Taguchi T, Kato Y, Baba Y, Nishimura G, Tanigaki Y, Horiuchi C, Mochimatsu I, Tsukuda M. Oncol Rep; 2004 Feb 15; 11(2):421-6. PubMed ID: 14719078 [Abstract] [Full Text] [Related]
17. Adenoviral delivery of p53 gene suppresses expression of collagenase-3 (MMP-13) in squamous carcinoma cells. Ala-aho R, Grénman R, Seth P, Kähäri VM. Oncogene; 2002 Feb 14; 21(8):1187-95. PubMed ID: 11850838 [Abstract] [Full Text] [Related]
18. p53-dependent G2 arrest associated with a decrease in cyclins A2 and B1 levels in a human carcinoma cell line. Badie C, Bourhis J, Sobczak-Thépot J, Haddada H, Chiron M, Janicot M, Janot F, Tursz T, Vassal G. Br J Cancer; 2000 Feb 14; 82(3):642-50. PubMed ID: 10682678 [Abstract] [Full Text] [Related]
19. p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents. Fan S, el-Deiry WS, Bae I, Freeman J, Jondle D, Bhatia K, Fornace AJ, Magrath I, Kohn KW, O'Connor PM. Cancer Res; 1994 Nov 15; 54(22):5824-30. PubMed ID: 7954409 [Abstract] [Full Text] [Related]
20. Expression of apoptosis and cell cycle related genes in proliferating and colcemid arrested cells of divergent lineage. Gallaher BW, Berthold A, Klammt J, Knüpfer M, Kratzsch J, Bartsch M, Kiess W. Cell Mol Biol (Noisy-le-grand); 2000 Feb 15; 46(1):79-88. PubMed ID: 10726974 [Abstract] [Full Text] [Related] Page: [Next] [New Search]